Larimar Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
BALA CYNWYD, Pa., Feb. 14, 2024 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused […]
VPG Reports Fiscal 2023 Fourth Quarter and Twelve Month Results
MALVERN, Pa., Feb. 14, 2024 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement technologies, […]
Centerra Gold Achieves 2023 Production Guidance; Begins 2024 with Over $600 Million in Cash and Cash Equivalents; Announces 2024 Outlook
All figures are in United States dollars. All production figures reflect payable metal quantities and are on a 100% basis, […]
Centerra Gold Announces 2023 Year-End Mineral Reserves and Resources and Provides Exploration Update
This news release contains forward-looking information that is subject to risk factors and assumptions as set out in the Cautionary […]
Iris Energy Triples AI Cloud Services Business to 816 NVIDIA H100 GPUs
SYDNEY, Australia, Feb. 14, 2024 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (together with its subsidiaries, “Iris Energy” or […]
Generac Reports Fourth Quarter and Full-Year 2023 Results
WAUKESHA, Wis., Feb. 14, 2024 (GLOBE NEWSWIRE) — Generac Holdings Inc. (NYSE: GNRC) (“Generac” or the “Company”), a leading global […]
TSX News -
Calibre’s Ore Control Drilling Intersects High-Grade Gold Outside of Reported Mineral Reserves Adding Additional Tonnes At The Valentine Gold Mine, Canada; Results Outside Mineral Reserves Include 46.53 g/t Gold Over 5.3 Metres and 17.16 g/t Gold Over 7.0 Metres
VANCOUVER, British Columbia, Feb. 14, 2024 (GLOBE NEWSWIRE) — Calibre (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) is pleased […]
Clear Strategies and Strong Partnerships Set Barrick Up to Outperform, Says Bristow
Fourth Quarter and Full Year 2023 ResultsAll amounts expressed in US dollars TORONTO, Feb. 14, 2024 (GLOBE NEWSWIRE) — Barrick […]
Centerra Gold Announces Mount Milligan Mine Life Extension and Additional Agreement with Royal Gold
TORONTO, Feb. 14, 2024 (GLOBE NEWSWIRE) — Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) is pleased […]
Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
STAFFORD, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused […]
